Identifying acutely ill medical patients requiring thromboprophylaxis [13]

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 4, 2006, Pages 915-916

  Chopard, P ^a   Spirk, D ^b   Bounameaux, Henri ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Sanofi Synthelabo (Switzerland)   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT;

ACUTE DISEASE; AGE; BLOOD CLOTTING DISORDER; CANCER; CHRONIC VEIN INSUFFICIENCY; CLINICAL PRACTICE; DATA ANALYSIS; DEHYDRATION; DRUG USE; EVIDENCE BASED PRACTICE; HEALTH SURVEY; HEART FAILURE; HEART INFARCTION; HORMONE SUBSTITUTION; HOSPITAL PATIENT; HUMAN; IMMOBILIZATION; INFECTION; LETTER; MEDICAL AUDIT; MEDICAL DECISION MAKING; MYELOPROLIFERATIVE DISORDER; NEPHROTIC SYNDROME; OBESITY; PREGNANCY; PRIORITY JOURNAL; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STANDARDIZATION; STROKE; THROMBOSIS; TRAVEL; TREATMENT INDICATION; VEIN THROMBOSIS;

ACUTE DISEASE; ANTICOAGULANTS; DATA COLLECTION; FEMALE; HOSPITALS; HUMANS; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; SWITZERLAND; THROMBOEMBOLISM; THROMBOSIS;

EID: 33644990631     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.01818.x     Document Type: Letter

References (10)

1. Chmelik P, Chopard P, Bounameaux H. An evaluation of thromboembolism prophylaxis in acutely ill medical patients. Swiss Med Wkly 2002; 132: 513-6.
2. Chopard P, Dörffler-Melly J, Hess U, Wuillemin WA, Hayoz D, Gallino A, Bächli EB, Canova CR, Isenegger J, Rubino R, Bounameaux H. Venous thromboembolism prophylaxis in acutely ill medical patients: definite need for improvement. J Intern Med 2005; 257: 352-7.
3. Lutz L, Haas S, Hach-Wunderle V, Betzl G, Jamartz H. Venous thromboembolism in internal medicine: Risk assessment and pharmaceutical prophylaxis. Med Welt 2002; 53: 231-4.
4. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG. Prevention of venous thromboembolism. Prevention of Venous Thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 338S-400S.
5. Samama MM, Cohen AT, Darmon JY, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Nguyen H, Olsson CG, Turpie AG, Weisslinger N. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999, 341: 793-800.
6. Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ for the PREVENT Medical Thromboprophylaxis Study Group. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004; 110: 874-9.
7. Aujesky D, Guignard E, Pannatier A, Cornuz J. Pharmacological thromboembolic prophylaxis in a medical ward. J Gen Intern Med 2002; 17: 788-91.
8. Rahim SA, Panju A, Pai M, Ginsberg J. Venous thromboembolism prophylaxis in medical inpatients: A retrospective chart review. Thromb Res 2003; 111: 215-9.
9. Fiessinger JN, Chatelier G. Effect of prescription and monitoring recommendations on prescription of low-molecular weight heparins. Presse med 1996; 25: 1777-80.
10. Bergmann JF, Kher A. Venous thromboembolism in the medically ill patient: A call to action. Int J Clin Pract 2005; 59: 555-61.